908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the …
Over the last 12 months, insiders at 908 Devices Inc. have bought $293,400 and sold $541,661 worth of 908 Devices Inc. stock.
On average, over the past 5 years, insiders at 908 Devices Inc. have bought $10.34M and sold $10.6M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Knopp Kevin J. (President and CEO) — $293,400.
The last purchase of 10,000 shares for transaction amount of $64,200 was made by Knopp Kevin J. (President and CEO) on 2024‑05‑13.
2024-05-13 | President and CEO | 10,000 0.0284% | $6.42 | $64,200 | -34.94% | |||
2024-05-10 | President and CEO | 10,000 0.0294% | $5.77 | $57,700 | -25.26% | |||
2024-05-09 | President and CEO | 10,000 0.0294% | $5.83 | $58,300 | -25.26% | |||
2024-05-08 | President and CEO | 10,000 0.0291% | $5.72 | $57,200 | -23.55% | |||
2024-05-07 | President and CEO | 10,000 0.0302% | $5.60 | $56,000 | -23.25% | |||
2024-02-02 | Sale | Chief Financial Officer | 9,711 0.029% | $7.09 | $68,873 | -20.39% | ||
2024-02-01 | Sale | Chief Product Officer | 3,957 0.0117% | $7.01 | $27,730 | -20.53% | ||
2024-02-01 | Sale | President and CEO | 9,071 0.0267% | $7.00 | $63,461 | -20.53% | ||
2024-02-01 | Sale | Chief Financial Officer | 5,698 0.0168% | $7.00 | $39,892 | -20.53% | ||
2024-02-01 | Sale | Chief Legal & Admin Officer | 5,232 0.0154% | $6.99 | $36,559 | -20.53% | ||
2023-12-28 | Sale | Chief Financial Officer | 6,000 0.0181% | $12.08 | $72,480 | -50.49% | ||
2023-12-21 | Sale | Chief Product Officer | 7,370 0.0228% | $9.12 | $67,214 | -32.31% | ||
2023-12-20 | Sale | Chief Product Officer | 5,235 0.0169% | $9.10 | $47,639 | -29.30% | ||
2023-12-19 | Sale | Chief Product Officer | 7,395 0.0229% | $9.08 | $67,147 | -31.97% | ||
2023-12-19 | Sale | Chief Financial Officer | 5,580 0.0173% | $9.08 | $50,666 | -31.97% | ||
2023-06-07 | Sale | Chief Product Officer | 4,470 0.0149% | $10.03 | $44,834 | -26.91% | ||
2023-05-23 | Sale | Chief Technology Officer | 10,000 0.0313% | $10.02 | $100,200 | -30.74% | ||
2023-05-23 | Sale | President and CEO | 60,000 0.1896% | $10.12 | $607,200 | -30.74% | ||
2023-02-16 | Sale | President and CEO | 4,842 0.0153% | $10.12 | $49,001 | -27.20% | ||
2023-02-15 | Sale | President and CEO | 15,158 0.0477% | $10.29 | $155,976 | -28.38% |
Knopp Kevin J. | President and CEO | 508981 1.4686% | $3.96 | 5 | 23 | |
Turner Michael S. | Chief Legal & Admin Officer | 9105 0.0263% | $3.96 | 1 | 8 | <0.0001% |
CRANDELL KEITH | 5725045 16.5193% | $3.96 | 1 | 0 | <0.0001% | |
ARCH Venture Fund VII, L.P. | 10 percent owner | 5725045 16.5193% | $3.96 | 1 | 0 | <0.0001% |
Kedar Sharon | director | 1077091 3.1079% | $3.96 | 1 | 0 | <0.0001% |
ARK Investment Management LLC | $30.57M | 11.74 | 4.05M | -6.85% | -$2.25M | 0.11 | |
Ameriprise Financial | $14.26M | 5.48 | 1.89M | -0.08% | -$11,264.60 | <0.01 | |
The Vanguard Group | $13.22M | 5.08 | 1.75M | +0.39% | +$51,128.60 | <0.0001 | |
Granahan Investment Management | $13.09M | 5.03 | 1.73M | -14.93% | -$2.3M | 0.46 | |
BlackRock | $13.09M | 5.03 | 1.73M | -3% | -$404,883.87 | <0.0001 |